Search Results
297 items found for "P2Y receptor"
- Complex Allosteric Cannabinoid Receptor Pharmacology
Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Complex Allosteric Cannabinoid Receptor
- Regulation and role of mitochondria delta opioid receptors
Committee Sponsors GPCR Retreat Program < Back to schedule Regulation and role of mitochondria delta opioid receptors pharmacology and has published seminal papers where he used various approaches to describe the role of opioid receptors anagesia as well as to study the mechanisms involved in the cellular trafficking of the delta opioid receptor
- G Protein-coupled Receptor-mediated Membrane Targeting of PLCγ2 is Essential for Neutrophil Chemotaxis
< GPCR News < GPCRs in Oncology and Immunology G Protein-coupled Receptor-mediated Membrane Targeting Published date April 11, 2023 Abstract " The current dogma is that chemoattractants G protein-coupled receptors (GPCRs) activate β phospholipase C (PLCβ) while receptor tyrosine kinases (RTKs) activate γ phospholipase Tags G protein-coupled receptor (GPCR) , calcium-promoted Ras inactivator (CAPRI) , chemotaxis , neutrophils
- Intermediate-state-trapped mutants pinpoint G protein-coupled receptor conformational allostery
News < GPCRs in Oncology and Immunology Intermediate-state-trapped mutants pinpoint G protein-coupled receptor intermediate states in signaling is pivotal to unraveling the activation processes of G protein-coupled receptors adopt distinct distributions among five states that lie along the activation pathway of adenosine A 2A receptor Intermediate-state-trapped mutants will also provide useful information in relation to receptor-G protein
- Single cell G-protein coupled receptor profiling of Transcription factor 21 expressing activated kidney fibroblasts
< GPCR News < GPCRs in Oncology and Immunology Single cell G-protein coupled receptor profiling of Transcription Activated fibroblasts deposit fibrotic matrix in chronic kidney disease (CKD) and G-protein coupled receptors The adenosine receptors, Adora2a/2b were upregulated in Tcf21+ fibroblasts and the adenosine receptor Tags Adenosine receptor , Fibroblast , Fibrosis , GPCR , Kidney , Tcf21 .
- G protein-coupled receptors related to autoimmunity in postural orthostatic tachycardia syndrome
< GPCR News < GPCRs in Oncology and Immunology G protein-coupled receptors related to autoimmunity in an increased rate of autoimmune comorbidities as evidenced by the finding of several types of neural receptor In particular, the association of the disease with several types of anti-G protein-coupled receptor ( Authors Yoko Sunami, Keizo Sugaya, Kazushi Takahashi Tags G protein-coupled receptors , Autoimmunity
- Plenary Lecture | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Plenary Lecture Identification and Functional Characterization of Adhesion GPCRs As Steroid Hormone Receptors and Hearing and Balance Receptors Abstract Only Available for AGPCR24 Attendees About Jin-Peng Sun " Since starting my laboratory in 2011, I has focused on G protein coupled receptors, in particular, the We have identified the receptor subfamily to sense the steroid hormones. progesterone and 17-hydroxyprogesterone membrane receptor are GPR126.
- Ep 111 with Chloe Hicks
contributed to multiple projects exploring the underlying mechanisms of biased signaling at chemokine receptor signaling profile of CXCR3’s three endogenous biased ligands, elucidating the role of site-specific receptor biased agonists, and demonstrating the ligand specificity behind GRK recruitment to endosomes upon receptor identifying the non-canonical signaling effectors involved in the activation of Atypical Chemokine Receptor 3 (ACKR3), a receptor which does not couple to G protein and has been shown to maintain its activation
- Ep 46 with Dr Gunnar Schulte
Gunnar Schulte Gunnar Schulte is a Professor in receptor pharmacology and research group leader for the section Receptor Biology and Signaling at the Department of Physiology and Pharmacology. University, Melbourne Australia, GPCR pharmacology; 2006) before starting his independent research team "Receptor Most importantly my research team tries to understand underlying mechanisms of WNT-receptor interaction , the relevance of receptor dynamics, and receptor complex composition for signal initiation and specification
- Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non-ischaemic heart failure
< GPCR News < GPCRs in Oncology and Immunology Receptor autoantibodies: Associations with cardiac markers causal link between non-ischaemic heart failure (HF) and humoral autoimmunity against G-protein-coupled receptors Here, we use validated and certified immune assays presenting native receptors as binding targets. GPCR autoantibodies were determined in serum by IgG binding to native receptors or a cyclic peptide ( Autoantibodies against α1 -adrenergic (α1 AR) and angiotensin II type 1 receptors (AT1R) were decreased
- Ep 45 with Dr Ralf Jockers
Strosberg AD in France, where he worked on the regulation of ß-adrenergic receptors. He is the Research director at INSERM with a specific interest in G protein-coupled receptors by developing He showed the formation of melatonin receptor heteromers in vitro and in vivo and their importance in He established the concept of ligand-independent functions of orphan receptors in heterodimers with other He discovered multiple rare and loss-of-function variants of the MT2 melatonin receptors that are associated
- Ep 13 with Dr. Amynah Pradhan
Paul Clarck , where she studied opioid receptors. AstraZeneca as a postdoctoral trainee, where she studied animal models of pain and sensory neuron sensitive-receptor Brigitte Kieffer , where she studied ligand-directed signaling at the delta-opioid receptor. Amynah studied how arrestins regulate ligand-directed signaling at delta-opioid receptors, and it is Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic
- Leukotriene B4 receptor 2 governs macrophage migration during tissue inflammation
< GPCR News < GPCRs in Oncology and Immunology Leukotriene B4 receptor 2 governs macrophage migration Although leukotriene B4 receptor 2 (BLT2) has been characterized as a low affinity receptor to several Kierstin Webster , Sarah A Tersey , Ryan M Anderson , Raghavendra G Mirmira Tags G-protein coupled receptor
- Severity of neurological long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors
correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors currently under heavy scrutiny and existing data on the role of auto-immune reaction to G-protein coupled receptors While autoantibodies towards the vasoregulation associated Adrenergic Receptor (ADR) B1 and B2 and the CNS and vasoregulation associated muscarinic acetylcholine receptor (CHR) M3 and M4 were measured by
- Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration
< GPCR News < GPCRs in Oncology and Immunology Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration Published date February 1 , 2023 Abstract "C-X-C chemokine receptor 4 (CXCR4) is widely overexpressed in various types of cancer The roles of histamine and histamine receptor H1 (HRH1) in cancer pathogenesis remain controversial.
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
< GPCR News < GPCRs in Oncology and Immunology C5aR2 receptor: The genomic twin of the flamboyant C5aR1 C5a is established to interact with a set of genomically related transmembrane receptors, like C5aR1 The C5aR1 is a classical G-protein-coupled receptor (GPCR), whereas C5aR2 is a nonclassical GPCR that Authors Aurosikha Das, Pulkit K Gupta, Soumendra Rana Tags C5a; C5aR2/C5L2 receptor; lipid bilayer; molecular
- Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling
< GPCR News < GPCRs in Oncology and Immunology Pharmacological inhibition of neuropeptide Y receptors NPY) is an abundant neurohormone in human breast carcinomas that acts on a class of G-protein coupled receptors that NPY1R and NPY5R mRNA abundance is increased by hypoxia inducible factors, which sensitizes these receptors The estrogen receptor positive MCF7 cells were significantly less invasive in 3D spheres when NPY5R was
- Classified News | Dr. GPCR Ecosystem
transmembrane domains modulates holo-adhesion GPCR function Read More September 25, 2024 The G Protein-Coupled Receptor Cell Migration Read More September 12, 2024 Loss of cardiomyocyte-specific Adhesion G Protein Coupled Receptor and dynamics simulation studies Read More December 1, 2024 Antibodies expand the scope of angiotensin receptor extracellular loops on a soluble scaffold enabled the discovery of antibodies, which recognized native receptor Read More Receptor Activation and Signaling in GPCRs December 9, 2024 Regulation of the chemokine receptors
- Dopamine-Mediated Motor Recovery after Ischemic Stroke
regulation of axonal transport by tricyclic antidepressants (M.Sc.) and molecular pharmacology of opioid receptors Marc Caron, where I cloned the dopamine D5 receptor gene and investigated the regulation of dopaminergic and adrenergic receptors. pursues the study of the molecular, structural, pharmacological and signaling features of dopamine (DA) receptors druggability potential of new signaling partners we identified that drive the formation of different DA receptor
- Identification of a G-protein coupled receptor-related gene signature through bioinformatics analysis to construct a risk model for ovarian cancer prognosis
< GPCR News < GPCRs in Oncology and Immunology Identification of a G-protein coupled receptor-related G protein-coupled receptors (GPCRs, the largest family of human cell surface receptors) are associated Shaohan Ma, Ruyue Li, Guangqi Li, Meng Wei, Bowei Li, Yongmei Li, Chunfang Ha Tags G protein-coupled receptor
- Ovarian cancer G protein-coupled receptor 1 (OGR1) deficiency exacerbates crystal deposition and kidney injury in oxalate nephropathy in female mice
< GPCR News < GPCRs in Oncology and Immunology Ovarian cancer G protein-coupled receptor 1 (OGR1) deficiency Published date July 11, 2023 Abstract "OGR1 (Gpr68) and GPR4 (Gpr4) are proton-activated G protein-coupled receptors These receptors have various physiological and pathophysiological roles in renal acid-base physiology Pellegrini , Nicole Joller , Carsten A Wagner , Pedro Henrique Imenez Silva Tags G-protein-coupled receptors
- G protein-coupled receptors: A target for microbial metabolites and a mechanistic link to microbiome-immune-brain interactions
< GPCR News < GPCRs in Oncology and Immunology G protein-coupled receptors: A target for microbial metabolites demonstrated that small-molecules from gut microbiota act as ligands for specific human G protein-coupled receptors permeability of the small-molecules we elucidated their molecular interactions with specific human cell receptors Authors Gajender Aleti , Emily A Troyer , Suzi Hong Tags G protein-coupled receptors , Gut microbiota
- Role and recent progress of P2Y12 receptor in cancer development
< GPCR News < GPCRs in Oncology and Immunology Role and recent progress of P2Y12 receptor in cancer development Published date June 14, 2024 Abstract "P2Y12 receptor (P2Y12R) is an adenosine-activated G protein-coupled receptor (GPCR) that plays a central role in platelet function, hemostasis, and thrombosis.
- Ep 01 with Dr. Paul Insel
That summer, he used radioligand binding methods to dissect receptor function from the adenylyl cyclase From that point on, Paul was hooked and has since studied receptor function in human physiology, receptor Today, Paul and his team focus on previously unrecognized receptors with the hopes to use these as novel
- Ep 33 with Dr. David E. Gloriam
Gloriam About this episode David Gloriam is a Professor in Computational Receptor Biology at the University University in Sweden where he worked on the bioinformatic identification of 24 novel human G protein-coupled receptors He later identified physiological hormones of such under characterized ‘orphan’ receptors and functional probes for a range of receptors. Gloriam on the web LinkedIn ResearchGate Twitter Google Scholar Computation Receptor Biology- Gloriam
- The GPCR adaptor protein Norbin controls the trafficking of C5aR1 and CXCR4 in mouse neutrophils
generally, by identifying its importance in β-arrestin recruitment, β-arrestin dependent agonist-induced receptor internalisation, and receptor recycling." A Chetwynd, Richard J Ward, Graeme Milligan, Heidi C E Welch Tags C5aR1 , CXCR4 , G protein-coupled receptor (GPCR) , GPCR trafficking , Ncdn , Neurochondrin , P-Rex1 , agonist-induced internalisation , receptor desensitization , receptor endocytosis , receptor recycling , β-arrestin Source Contribute to the GPCR
- Ep 82 with Dr. Lauren M. Slosky
Slosky’s research is focused on understanding how neuropeptide G protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic benefit. These ligands stimulate receptor β-arrestin recruitment without activating canonical G protein signaling addiction-associated behaviors in animal models without the side effects characteristic of balanced receptor Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor
- Exploration of prognostic and treatment markers in hepatocellular carcinoma via GPCR-related genes analysis
via GPCR-related genes analysis Published date May 15, 2024 Abstract " Background: G protein-coupled receptors (GPCRs), the biggest family of signaling receptors, account for 34 % of all the drug targets approved Results: A GPCR-related risk score containing eight GPCR-related genes (atypical chemokine receptor 3 receptor 8 (GRM8), hydroxycarboxylic acid receptor 1 (HCAR1), 5-hydroxytryptamine receptor 5A (HTR5A ) and nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 6 (NLRP6